People · Operator
Named in public records as an officer, director or promoter · active 2011–2011 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Theron Pharmaceuticals, Inc. | — | Pharmaceuticals | Pre-Seed | $2.2M | $19.4M | 2011 |
Allan Sundaram Kramer, M.D. at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Allan Sundaram Kramer, M.D. on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| JAMES W. LARRICK | 1 | 2 |
| Meenakshi Sundaram Venkatraman | 1 | 1 |
| Xiaoming R. Zhang | 1 | 1 |
| James Sundaram Larrick | 1 | 1 |
| Jurg R. Pfister | 1 | 1 |
| Cary Sundaram Queen, Ph.D. | 1 | 1 |
| Xiaoming Zhang | 1 | 1 |
| Allan W. Kramer, M.D. | 1 | 1 |
| Cary W. Queen, Ph.D. | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.